Archive for February, 2026

๐˜๐จ๐ฎ ๐€๐ซ๐ž ๐ญ๐ก๐ž ๐€๐ซ๐œ๐ก๐ข๐ญ๐ž๐œ๐ญ: ๐“๐ก๐ž ๐๐จ๐ฐ๐ž๐ซ ๐จ๐Ÿ ๐๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ž ๐๐ž๐ฎ๐ซ๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ข๐œ๐ข๐ญ๐ฒ

Posted by Michael A. S. Guth on February 23rd, 2026

๐’๐ญ๐จ๐ฉ ๐ญ๐ก๐ข๐ง๐ค๐ข๐ง๐  ๐จ๐Ÿ ๐ฒ๐จ๐ฎ๐ซ ๐›๐ซ๐š๐ข๐ง ๐š๐ฌ ๐š ๐ฌ๐ญ๐š๐ญ๐ข๐œ ๐จ๐ซ๐ ๐š๐ง ๐ญ๐ก๐š๐ญ ๐จ๐ง๐ฅ๐ฒ ๐๐ž๐œ๐ฅ๐ข๐ง๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐š๐ ๐ž. ๐ˆ๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”, ๐ฐ๐ž ๐ก๐š๐ฏ๐ž ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฎ๐ญ๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐ฉ๐ซ๐จ๐จ๐Ÿ ๐ญ๐ก๐š๐ญ ๐ฒ๐จ๐ฎ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐š๐ซ๐œ๐ก๐ข๐ญ๐ž๐œ๐ญ ๐จ๐Ÿ ๐ฒ๐จ๐ฎ๐ซ ๐จ๐ฐ๐ง ๐ ๐ซ๐ž๐ฒ ๐ฆ๐š๐ญ๐ญ๐ž๐ซ. ๐–๐ž ๐œ๐š๐ฅ๐ฅ ๐ญ๐ก๐ข๐ฌ ๐๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ž ๐๐ž๐ฎ๐ซ๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ข๐œ๐ข๐ญ๐ฒ, ๐š๐ง๐ ๐ข๐ญ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐ž๐ฆ๐ฉ๐จ๐ฐ๐ž๐ซ๐ข๐ง๐  ๐ฌ๐œ๐ข๐ž๐ง๐ญ๐ข๐Ÿ๐ข๐œ ๐ซ๐ž๐š๐ฅ๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐จ๐ฎ๐ซ ๐ญ๐ข๐ฆ๐ž. ๐˜๐จ๐ฎ๐ซ ๐›๐ซ๐š๐ข๐ง ๐ข๐ฌ ๐š ๐๐ฒ๐ง๐š๐ฆ๐ข๐œ, ๐Ÿ๐ฅ๐ฎ๐ข๐ ๐œ๐ข๐ซ๐œ๐ฎ๐ข๐ญ ๐ญ๐ก๐š๐ญ […]

Posted in Regulatory Medical Writing Comments Off on ๐˜๐จ๐ฎ ๐€๐ซ๐ž ๐ญ๐ก๐ž ๐€๐ซ๐œ๐ก๐ข๐ญ๐ž๐œ๐ญ: ๐“๐ก๐ž ๐๐จ๐ฐ๐ž๐ซ ๐จ๐Ÿ ๐๐จ๐ฌ๐ข๐ญ๐ข๐ฏ๐ž ๐๐ž๐ฎ๐ซ๐จ๐ฉ๐ฅ๐š๐ฌ๐ญ๐ข๐œ๐ข๐ญ๐ฒ
Read More »

๐“๐ก๐ž “๐’๐ก๐š๐ฉ๐ž” ๐จ๐Ÿ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง: ๐–๐ก๐ฒ ๐Œ๐จ๐ซ๐ฉ๐ก๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐‘๐–๐„ ๐ข๐ง ๐‚๐๐’

Posted by Michael A. S. Guth on February 23rd, 2026

๐‡๐ž๐š๐๐ฅ๐ข๐ง๐ž: ๐“๐ก๐ž “๐’๐ก๐š๐ฉ๐ž” ๐จ๐Ÿ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง: ๐–๐ก๐ฒ ๐Œ๐จ๐ซ๐ฉ๐ก๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐‘๐–๐„ ๐ข๐ง ๐‚๐๐’ In the high-stakes world of CNS drug discovery and Real-World Evidence (RWE), weโ€™ve leaned on behavioral scales for too long. But in 2026, the data is clear: Morphological Biomarkers are the new gold standard. Recent advancements in Geometric Morphometrics prove […]

Posted in Featured, Neuroplasticity Comments Off on ๐“๐ก๐ž “๐’๐ก๐š๐ฉ๐ž” ๐จ๐Ÿ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง: ๐–๐ก๐ฒ ๐Œ๐จ๐ซ๐ฉ๐ก๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ซ๐ฌ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐‘๐–๐„ ๐ข๐ง ๐‚๐๐’
Read More »

Beyond Volume: Decoding “Positive” Neuroplasticity through Geometric Procrustes Surface Analysis (GPSA)

Posted by Michael A. S. Guth on February 23rd, 2026

The study of vertebrate brain morphology has entered a transformative era. While traditional neuroimaging has long relied on rectilinear volume or labeled atlases, these methods often struggle with the “correspondence problem”โ€”the extreme anatomical variation of the human cortical surface. At the Institute for Neuroplasticity Research, we are closely following the shift toward Generalized Procrustes Surface […]

Posted in Neuroplasticity Comments Off on Beyond Volume: Decoding “Positive” Neuroplasticity through Geometric Procrustes Surface Analysis (GPSA)
Read More »

Beyond the BBB: Mapping the 2026 Milestone Year for Neuroscience

Posted by Michael A. S. Guth on February 18th, 2026

Beyond the BBB: Mapping the 2026 Milestone Year for Neuroscience.ย  As we move through Q1, all eyes in the neuroscience community are on April 5, 2026โ€”the PDUFA target action date for tividenofusp alfa (DNL310). If approved, tividenofusp alfa will be a watershed moment: the first commercial validation of a Transport Vehicle (TV) enabled enzyme replacement […]

Posted in Featured, Regulatory Medical Writing Comments Off on Beyond the BBB: Mapping the 2026 Milestone Year for Neuroscience
Read More »

“Chemo Brain” and Diabetes Research

Posted by Michael A. S. Guth on February 10th, 2026

Is the Next Breakthrough in “Chemo Brain” Treatment Hiding in Diabetes Research? For cancer survivors, the battle often doesn’t end with remission. Chemotherapy-Induced Cognitive Impairment (CICI)โ€”widely known as “Chemo Brain”โ€”remains one of the most debilitating long-term side effects of treatment, affecting memory, executive function, and attention. While the clinical impact is well-documented, therapeutic options remain […]

Posted in Featured, Neuroplasticity, Pharma and Medical Device Comments Off on “Chemo Brain” and Diabetes Research
Read More »

๐–๐ก๐ฒ ๐ƒ๐๐€ ๐Ž๐ซ๐ข๐ ๐š๐ฆ๐ข ๐ข๐ฌ ๐ญ๐ก๐ž ๐’๐ž๐œ๐ซ๐ž๐ญ ๐ญ๐จ ๐š “๐’๐ข๐ฅ๐ž๐ง๐ญ” ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐’๐œ๐š๐Ÿ๐Ÿ๐จ๐ฅ๐ ๐ˆ๐ง ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐๐ž๐ฌ๐ข๐ ๐ง,

Posted by Michael A. S. Guth on February 7th, 2026

๐–๐ก๐ฒ ๐ƒ๐๐€ ๐Ž๐ซ๐ข๐ ๐š๐ฆ๐ข ๐ข๐ฌ ๐ญ๐ก๐ž ๐’๐ž๐œ๐ซ๐ž๐ญ ๐ญ๐จ ๐š “๐’๐ข๐ฅ๐ž๐ง๐ญ” ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐’๐œ๐š๐Ÿ๐Ÿ๐จ๐ฅ๐ ๐ˆ๐ง ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐๐ž๐ฌ๐ข๐ ๐ง, “๐จ๐Ÿ๐Ÿ-๐ญ๐š๐ซ๐ ๐ž๐ญ” ๐ซ๐ž๐ฌ๐ฉ๐จ๐ง๐ฌ๐ž๐ฌ ๐š๐ซ๐ž ๐š ๐ฉ๐ž๐ซ๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐ญ ๐ก๐ฎ๐ซ๐๐ฅ๐ž. ๐–๐ก๐ž๐ง ๐ฐ๐ž ๐ฎ๐ฌ๐ž ๐ฉ๐ซ๐จ๐ญ๐ž๐ข๐ง-๐›๐š๐ฌ๐ž๐ ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž๐ฌ ๐ญ๐จ ๐๐ž๐ฅ๐ข๐ฏ๐ž๐ซ ๐š๐ง ๐š๐ง๐ญ๐ข๐ ๐ž๐ง, ๐ญ๐ก๐ž ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ฌ๐ฒ๐ฌ๐ญ๐ž๐ฆ ๐จ๐Ÿ๐ญ๐ž๐ง ๐ ๐ž๐ญ๐ฌ ๐๐ข๐ฌ๐ญ๐ซ๐š๐œ๐ญ๐ž๐ ๐š๐ง๐ ๐š๐ญ๐ญ๐š๐œ๐ค๐ฌ ๐ญ๐ก๐ž ๐๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐ฏ๐ž๐ก๐ข๐œ๐ฅ๐ž ๐ข๐ญ๐ฌ๐ž๐ฅ๐Ÿ ๐ข๐ง๐ฌ๐ญ๐ž๐š๐ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฏ๐ข๐ซ๐ฎ๐ฌ. ๐๐ž๐ฐ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Ÿ๐ซ๐จ๐ฆ ๐Œ๐ˆ๐“ ๐š๐ง๐ ๐’๐œ๐ซ๐ข๐ฉ๐ฉ๐ฌ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก, ๐ฉ๐ฎ๐›๐ฅ๐ข๐ฌ๐ก๐ž๐ ๐ข๐ง ๐’๐œ๐ข๐ž๐ง๐œ๐ž, […]

Posted in Pharma and Medical Device, Regulatory Medical Writing Comments Off on ๐–๐ก๐ฒ ๐ƒ๐๐€ ๐Ž๐ซ๐ข๐ ๐š๐ฆ๐ข ๐ข๐ฌ ๐ญ๐ก๐ž ๐’๐ž๐œ๐ซ๐ž๐ญ ๐ญ๐จ ๐š “๐’๐ข๐ฅ๐ž๐ง๐ญ” ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐’๐œ๐š๐Ÿ๐Ÿ๐จ๐ฅ๐ ๐ˆ๐ง ๐ฏ๐š๐œ๐œ๐ข๐ง๐ž ๐๐ž๐ฌ๐ข๐ ๐ง,
Read More »

๐—ก๐—œ๐—–๐—˜ ๐—ฅ๐—ฒ๐—ฐ๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐—ฑ๐˜€ ๐——๐˜‚๐—ฝ๐—ถ๐—น๐˜‚๐—บ๐—ฎ๐—ฏ ๐—ณ๐—ผ๐—ฟ ๐—˜๐—ผ๐˜€๐—ถ๐—ป๐—ผ๐—ฝ๐—ต๐—ถ๐—น๐—ถ๐—ฐ ๐—–๐—ข๐—ฃ๐——: ๐—” ๐——๐—ฒ๐—ฒ๐—ฝ ๐——๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ฐ๐—ผ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ ๐—–๐—ฎ๐˜€๐—ฒ

Posted by Michael A. S. Guth on February 7th, 2026

๐—ก๐—œ๐—–๐—˜ ๐—ฅ๐—ฒ๐—ฐ๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐—ฑ๐˜€ ๐——๐˜‚๐—ฝ๐—ถ๐—น๐˜‚๐—บ๐—ฎ๐—ฏ ๐—ณ๐—ผ๐—ฟ ๐—˜๐—ผ๐˜€๐—ถ๐—ป๐—ผ๐—ฝ๐—ต๐—ถ๐—น๐—ถ๐—ฐ ๐—–๐—ข๐—ฃ๐——: ๐—” ๐——๐—ฒ๐—ฒ๐—ฝ ๐——๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ฐ๐—ผ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ ๐—–๐—ฎ๐˜€๐—ฒ ๐—ง๐—ต๐—ฒ ๐—จ๐—ž’๐˜€ ๐—ก๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐˜๐—ถ๐˜๐˜‚๐˜๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ฎ๐—ป๐—ฑ ๐—–๐—ฎ๐—ฟ๐—ฒ ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ (๐—ก๐—œ๐—–๐—˜) ๐—ต๐—ฎ๐˜€ ๐—ถ๐˜€๐˜€๐˜‚๐—ฒ๐—ฑ ๐—ณ๐—ถ๐—ป๐—ฎ๐—น ๐—ฑ๐—ฟ๐—ฎ๐—ณ๐˜ ๐—ด๐˜‚๐—ถ๐—ฑ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฟ๐—ฒ๐—ฐ๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—ฑ๐˜‚๐—ฝ๐—ถ๐—น๐˜‚๐—บ๐—ฎ๐—ฏ ๐—ฎ๐˜€ ๐—ฎ๐—ป ๐—ฎ๐—ฑ๐—ฑ-๐—ผ๐—ป ๐—บ๐—ฎ๐—ถ๐—ป๐˜๐—ฒ๐—ป๐—ฎ๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐˜€๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ, ๐—ต๐—ถ๐—ด๐—ต-๐—ป๐—ฒ๐—ฒ๐—ฑ ๐—–๐—ข๐—ฃ๐—— ๐—ฝ๐—ผ๐—ฝ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป. ๐—ง๐—ต๐—ถ๐˜€ ๐—บ๐—ฎ๐—ฟ๐—ธ๐˜€ ๐—ฎ ๐—ฝ๐—ถ๐˜ƒ๐—ผ๐˜๐—ฎ๐—น ๐˜€๐—ต๐—ถ๐—ณ๐˜ ๐˜๐—ผ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ฝ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ถ๐—ป ๐—ฐ๐—ต๐—ฟ๐—ผ๐—ป๐—ถ๐—ฐ ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ. […]

Posted in Pharma and Medical Device, Regulatory Medical Writing Comments Off on ๐—ก๐—œ๐—–๐—˜ ๐—ฅ๐—ฒ๐—ฐ๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐—ฑ๐˜€ ๐——๐˜‚๐—ฝ๐—ถ๐—น๐˜‚๐—บ๐—ฎ๐—ฏ ๐—ณ๐—ผ๐—ฟ ๐—˜๐—ผ๐˜€๐—ถ๐—ป๐—ผ๐—ฝ๐—ต๐—ถ๐—น๐—ถ๐—ฐ ๐—–๐—ข๐—ฃ๐——: ๐—” ๐——๐—ฒ๐—ฒ๐—ฝ ๐——๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—˜๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—˜๐—ฐ๐—ผ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ ๐—–๐—ฎ๐˜€๐—ฒ
Read More »